OTC · CNNA
Cann American Corp.
$0.01$0.00 (0.0%)
Cann American Corp.’s quoted price sits in the upper half of its reported 52-week range, 43.88% below the high.
Loading market information…
OTC · ALID · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Allied Corp.’s quoted price sits in the lower half of its reported 52-week range, 95.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Allied Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Allied Corp. (ALID) specializes in the research, development, and production of cannabinoid health solutions, primarily operating in the United States. The company markets a diverse portfolio of natural health products derived from hemp under various brands. Its "Tactical Relief" line features items such as Liberty, a CBD tincture; Tactical Hydration, a CBD-infused electrolyte beverage; FIZZ Tablets designed for water bottles; Battle Balm, a CBD roll-on formulated for activity-related aches and pains; and Quick Hit, a CBD gummy. Similarly, the "Equilibrium Bio" brand encompasses Hydrosport CBD Drink, an electrolyte beverage fortified with sodium citrate; Hydrosport Tincture, a CBD tincture enhanced with specific terpene profiles; FIZZ Tablets for customizable drinks; Sport Rub, a CBD topical for post-activity muscle relief; and Quick Hit, a CBD gummy enriched with vitamin B12. Additionally, Allied Corp. distributes a specialized skincare line under its "MaXXa" brand. This collection features Skin Structure, a facial formula for enhancing skin radiance and youthfulness; Eye Recover, designed to protect delicate eye skin from free radicals and sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer, stimulating cell regeneration and minimizing age spots; Vitamin Absolute, a hydrating facial oil; and Absolute Recover, a formulation for direct delivery of bioactive compounds to address inflammation, pain, and other skin ailments. Beyond its consumer product portfolio, Allied Corp. is also engaged in pharmaceutical development, with ALID 10 and ALID 11, experimental drug candidates, currently in Phase I clinical trials for the treatment of post-traumatic stress disorder (PTSD). Established in 2013, Allied Corp. maintains its corporate headquarters in Kelowna, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01$0.00 (0.0%)
Cann American Corp.’s quoted price sits in the upper half of its reported 52-week range, 43.88% below the high.
$0.00+$0.00 (+5.0%)
CannaPharmaRX, Inc.’s quoted price sits in the lower half of its reported 52-week range, 79.0% below the high.
$0.00-$0.00 (-25.0%)
Anything Technologies Media, Inc.’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
$0.01$0.00 (0.0%)
Mystic Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 41.52% below the high.
$0.00-$0.00 (-25.0%)
Medical Marijuana, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
$0.00$0.00 (0.0%)
Target Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.52% below the high.
$1.17$0.00 (0.0%)
Pharmagreen Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.29% below the high.
$0.00$0.00 (0.0%)
Yooma Wellness Inc’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
